Targeting the lncrna fgd5-as1/mir-497-5p/pd-l1 axis inhibits malignant phenotypes in colon cancer (cc)

HIGHLIGHTS

• who: Lijuan Zhang et al. from the The Department of Pathology, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunzhou Road No519, Kunming City, Yunnan Province, China have published the research: Targeting the lncRNA FGD5-AS1/miR-497-5p/PD-L1 Axis Inhibits Malignant Phenotypes in Colon Cancer (CC), in the Journal: BioMed Research International of 18/03/2022
• what: This study investigated the role of lncRNA FGD5-AS1 in regulating colon cancer (CC) progression and found that lncRNA FGD5-AS1 regulated miR-497-5p/PD-L1 axis to promote cancer progression . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.